![](https://investorshub.advfn.com/uicon/682025.png?cb=1572439110)
Wednesday, June 29, 2022 2:19:18 PM
By: Tomas Ronolski - AllPennyStocks.com News
Wednesday, June 22, 2022
In the biotech space, sometimes all it takes for a stock to move is a simple indication that things are going well during a specific trial or if there is any mention of the FDA. Just today, a small biotech company announced that the results from a small trial of just 18 rectal cancer patients in complete remission using an immunotherapy called dostarlimab are “impressive,” whilst acknowledging there’s more work to be done, according to the release. This simple mention sent shares of Propanc Biopharma Inc. (OTCQB:PPCB) soaring on Wednesday.
https://www.allpennystocks.com/specialreportsus/2997/sometimes-all-it-takes-is-a-mention
Recent PPCB News
- Biopharma on a Tear After Certificate of Grant from Japanese Patent Office • AllPennyStocks.com • 06/25/2024 04:26:00 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM